BIG PHARMA WATCH: PHARMA PATENTS INVALIDATED MORE THAN ANY OTHER INDUSTRY FOR MISREPRESENTED OR OMITTED INFORMATION
Analysis Finds Bogus and Faulty Patents Contribute to Rising Prescription Drug Launch Prices According to coverage in STAT News, a recent analysis published in the Journal of the American Medical Association (JAMA) found U.S. Food and Drug Administration (FDA) approved patents secured by Big Pharma are more frequently invalidated than any other industry sector due to